Showing results (151-160 of 359) with videos related to
Sort By:
Pageof 36
BMJ Open|November 17, 2025
LSTA1-GBM-2A: study protocol for an exploratory phase 2a randomised controlled trial evaluating tumour-homing peptide certepetide with temozolomide in glioblastoma multiformeJohannes Pärtel Truusalu, Kersti Oselin, Jana Lass, et al.The Journal of Surgical Research|August 6, 2025
Opioid Use Within a Year Following Discharge in Trauma Patients With Prior Opioid Use DisorderHannah Bard, Samantha Watts, Gurkeerat Singh, et al.Theranostics|February 16, 2016
11C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow InvolvementConstantin Lapa, Stefan Knop, Martin Schreder, et al.Cancers|June 10, 2022
Associations between Normal Organs and Tumor Burden in Patients Imaged with Fibroblast Activation Protein Inhibitor-Directed Positron Emission TomographyAleksander Kosmala, Sebastian E Serfling, Niklas Dreher, et al.The Pediatric Infectious Disease Journal|June 1, 1995
Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trialJ S Garland, R K Buck, P Maloney, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 9, 2009
Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CTStefan Krüger, Andreas K Buck, Felix M Mottaghy, et al.Plos One|March 26, 2015
Tumor-associated macrophages in glioblastoma multiforme-a suitable target for somatostatin receptor-based imaging and therapy?Constantin Lapa, Thomas Linsenmann, Katharina Lückerath, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2021
Biokinetics and Dosimetry of 177Lu-PentixatherHeribert Hänscheid, Andreas Schirbel, Philipp Hartrampf, et al.Cancer Research|June 18, 2002
3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodulesAndreas K Buck, Holger Schirrmeister, Martin Hetzel, et al.Social Science & Medicine (1982)|July 12, 2025
From dealer to doctor: A case study examining how Purdue Pharma sought to leverage racial health disparities to attenuate flagging OxyContin salesEmily Rosenman, Ruth K Buck, Nafisa Anjum, et al.Pageof 36